Conversely, down-regulation of MAP3K2 and MAP3K3 in CRC, as seen in GC, may lead to dysregulation of apoptosis, cell cycle control, and immune responses, contributing to tumor development and aggressiveness. This evidence concerns the gene MAP3K3 and gastric cancer.